SML1530

SB-334867

≥98% (HPLC)

• Synonim(y): N-(2-Methyl-6-benzoxazolyl)-N′-1,5-naphthyridin-4-yl-urea, SB-334867, SB-334867A, SB334867
• Wzór empiryczny (zapis Hilla): C₁₇H₁₃N₅O₂
• Numer CAS: 792173-99-0
• Masa cząsteczkowa: 319.32
• NACRES: NA.77
• PubChem Substance ID: 329825947
• UNSPSC Code: 51111800
• MDL number: MFCD06411602
• Assay: ≥98% (HPLC)
• Form: powder
• Storage condition: desiccated

Właściwości

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• storage condition: desiccated
• color: white to beige
• solubility: DMSO: 5 mg/mL, clear (warmed)
• storage temp.: room temp
• SMILES string: O=C(NC1=CC=C(N=C(C)O2)C2=C1)NC3=CC=NC4=C3N=CC=C4
• InChI: 1S/C17H13N5O2/c1-10-20-12-5-4-11(9-15(12)24-10)21-17(23)22-14-6-8-18-13-3-2-7-19-16(13)14/h2-9H,1H3,(H2,18,21,22,23)
• InChI key: AKMNUCBQGHFICM-UHFFFAOYSA-N

Opis

Biochem/physiol Actions

SB-334867 is a non-peptide selective antagonist of the orexin OX1 receptor.

SB-334867 is a non-peptide selective antagonist of the orexin OX1 receptor. SB-334867 blocks orexin-A induced calcium response with a pKb of 7.23. SB-334867 blocks increases in heart rate and body temperature induced by administratin of methamphetamine, and can inhibit the development of tolerance to the analgesic properties of morphine in rodent models. SB-334867 also shows anxiolytic and sedative effects.

Lateral hypothalamic orexin neuron activation leads to the development of morphine conditioned place preference, which is preferably blocked by SB-334867.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Piktogramy: GHS07
• Słowo ostrzegawcze: Warning
• Kody zagrożeń: H315
• Ostrzeżenia: P264 - P280 - P302 + P352 - P332 + P313 - P362 + P364
• Hazard Classifications: Skin Irrit. 2
• Klasa składowania: 11 - Combustible Solids
• Co się dzieje?: WGK 3
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable